About My Health Careers Internship MedBlogs Contact us

Researchers Find the Reason for Failure of HIV Vaccine

by VR Sreeraman on November 7, 2008 at 1:20 PM
Font : A-A+

 Researchers Find the Reason for Failure of HIV Vaccine

A team of researchers says that the reason why the STEP trial of an experimental vaccine against AIDS failed could be partially because it made some people's immune cells more vulnerable to HIV infection.

Lead researcher Eric Kremer, of the University of Montpellier in France, said that the research group examined why people participating in the STEP vaccine trial who had previously been exposed to a cold virus, adenovirus 5, seemed more likely to become infected with HIV-1 than those who hadn't been exposed to the virus.


Some researchers had speculated that since the STEP vaccine's backbone was made from a modified version of adenovirus 5, it might be recognized by pre-existing antibodies in people who had previously been infected with this virus and eliminated from the body before an immune response to HIV-1 could develop.

However, Kremer's team discovered that when antibodies to adenovirus 5 were combined with the vaccine backbone in a culture dish, they triggered a pathway that causes the activation of certain immune cells called T cells, which are targeted by HIV in their active state.

The researchers revealed that in cell culture, T cells succumbed to HIV-1 infection three times more quickly than did those in a mixture that lacked adenovirus 5 antibodies.

According to them, their findings show how injecting an adenovirus-5-based vaccine into people with adenovirus 5 antibodies could have created a "chronic permissive environment for HIV-1 infection"1.

Warner Greene, the director of the Gladstone Institute of Virology and Immunology in San Francisco, who was not involved in the work, said that the study's results indicated that HIV-1 "encounters a singularly target-rich environment favouring successful HIV transmission" in people who had previous exposure to adenovirus 5.

However, there are many researchers who are not convinced that the new findings explain what went wrong in the original trial.

The experiments conducted by the research group were done in culture dishes, and did not use cells or antibodies taken from individuals who were actually involved in the STEP trial.

"I think that it outlines a very interesting hypothesis that might explain some of the STEP data," Nature magazine quoted Larry Corey, leader of the HIV Vaccine Trials Network, which conducted the STEP trial, as saying.

But he cautions: "One should recognize that the data presented are still largely in vitro and that further experiments to define whether this occurred among vaccinees in STEP need to be done."

Jonathan Yewdell of the US National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, says that he is "dubious that this mechanism plays an important role in the HIV trial findings," because the events that it suggests make cells more vulnerable to HIV are probably "too transient to account for infections occurring weeks after vaccination."

"They're building on a series of reasonable hypotheses, but there are lots of alternative ways this could be happening," says Jeffrey Ravetch of the Rockefeller University in New York.

He, however, still hailed the attempt to find out why the STEP trial failed.

"It's a very important exercise. You have to try to understand what went wrong so you can design the next (vaccine) with that information in mind," he said.

Source: ANI

News A-Z
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Oral Health And AIDS AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Prostitution: Fresh Stakes in the Oldest Trade HIV Symptom 

Recommended Reading
AIDS / HIV - Treatment
Encyclopedia section of medindia explains in brief about the treatment for AIDS/HIV...
Malawi Gets Grant of $20 Million to Fight AIDS, HIV
Malawi, one of Africa's poorest nations, has received 20 million dollars (15.4 million euros) from ....
AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV...
How to use a condom - Animation
This Interactive provides step by step visual aid showing how to correctly use condoms which can ......
"AIDS is an epidemic disease, a potentially preventable, deadly infection for which there is no cure...
AIDS/HIV - Clinical Features
Encyclopedia section of medindia gives general info about HIV Clinical Features...
AIDS/HIV - Epidemiology
AIDS or HIV is an epidemic disease, a potentially deadly infection that can be prevented with preca...
AIDS/HIV - Health Education
Encyclopedia section of medindia gives general info about AIDS information and health education....
Oral Health And AIDS
AIDS has taken on massive proportions in modern times. It is estimated that over 15 million people a...
Prostitution: Fresh Stakes in the Oldest Trade
Prostitution has broadened its base to include street prostitution, massage brothels, gigolo outcall...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use